MEMBRANE DAMAGE BY IMMUNE MECHANISMS
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
批准号:
3962935
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
T lymphocyte antigen antibody reaction antiidiotype antibody cell death cell mediated cytotoxicity cell membrane cellular immunity cellular oncology complement cytolysins cytolysis deoxyribonuclease I electrical measurement erythrocyte membrane fluorescence microscopy fluorescent dye /probe granule ion transport liposomes lymphocyte membrane activity membrane permeability membrane potentials microelectrodes myeloma globulin neoplasm /cancer immunology surface antigens tissue /cell culture
中文摘要
从大鼠大颗粒淋巴细胞瘤中提纯的胞浆颗粒
已有研究确定其在细胞毒和细胞毒性中的作用
这些淋巴细胞的其他功能。除了主要的裂解
一种名为细胞溶素的蛋白质,我们发现了一系列的蛋白酶活性
存在于纯化的致密颗粒中。其中的两个,它们显示出强大的
对胰酶硫酯底物(BLT)的活性一直是
纯化至均一,是主要的颗粒蛋白之一。其中之一
这些酶是由两个约30kd蛋白质组成的二硫键连接的二聚体。
链,而另一个由约27kd的单链组成。
这些酶不容易水解被
胰酶,但可以作用于几种合成肽
对-硝基苯胺底物与精氨酸在P1位。抑制剂研究
结果表明,两种酶均为丝氨酸蛋白酶,最适pH约为8。
一组抑制剂对两种酶的活性抑制模式
酶是不同的,这表明这两种酶不共享
简单的单体-二聚体关系。除了这两个之外
纯化的BLT-水解酶、颗粒提取物
经凝胶过滤分离后显示出一个额外的抗病毒活性峰
胰酶对硝基苯胺底物和2-3个抗菌活性高峰
胰凝乳酶对硝基苯胺底物。虽然生理上的作用
这些丝氨酸蛋白酶中的每一种仍不清楚,分别是纯化的两种
BLT-水解酶能协同促进有核物质的裂解
用纯化的细胞溶血素颗粒培养细胞。颗粒状蛋白多糖的研究进展
已经通过标记体内生长的LGL肿瘤进行了研究
35S-S04。研究发现,该标记在致密的两种细胞中均有定位
(细胞溶血素阳性)和轻(裂解不活跃)颗粒组分
Percoll分级匀浆;动力学研究表明,光
颗粒组分是致密颗粒组分的前驱物质。西式
Percoll梯度与兔抗细胞溶血素抗体免疫印迹显示
溶细胞素蛋白存在于轻颗粒组分中,尽管
缺乏可分解的活动。
英文摘要
The cytoplasmic granules purified from rat large granular lymphocyte tumors
with NK activity have been studied to determine their role in cytotoxic and
other functions of these lymphocytes. In addition to the major lytic
protein termed cytolysin, we have found a series of protease activities
present in the purified dense granules. Two of these, which show potent
activity against the trypsin thioester substrate known as BLT, have been
purified to homogeneity and are among the major granule proteins. One of
these enzymes is a disulfide linked dimer of two roughly 30kd protein
chains, while the other is comprised of a single chain of about 27kd.
These enzymes do not readily hydrolyze protein substrates cleaved by
trypsin, but can be shown to act on several synthetic peptide
p-nitroanilide substrates with arginine at the P1 site. Inhibitor studies
show that both enzymes are serine proteases with a pH optimum of about 8.
The pattern of activity inhibition by a panel of inhibitors on the two
enzymes is distinct, indicating that these two enzymes do not share a
simple monomer-dimer relationship. In addition to these two
BLT-hydrolyzing enzymes which have been purified, granule extracts
separated by gel filtration show an additional peak of activity against
tryptic p-nitroanilide substrates, and 2-3 peaks of activity against
chymotryptic p-nitroanilide substrates. Although the physiological roles
of these serine proteases are still unclear, each of the two purified
BLT-hydrolysing enzymes can synergistically enhance the lysis of nucleated
cells by the purified granule cytolysin. Studies of granule proteoglycans
have been undertaken by labeling the growing LGL tumors in vivo with
35S-S04. It was found that this label is localized in both dense
(cytolysin positive) and light (lytically inactive) granule fractions of
Percoll fractionated homogenates; kinetic studies suggest that the light
granule fraction is a precursor of the dense granule fraction. Western
blots of Percoll gradients with rabbit anti-cytolysin antibody show that
the cytolysin protein is present in the light granule fraction in spite of
the lack of dectable activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3752088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
海外基金